0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessAZD9773 rapidly and efficiently decreased plasma tumor necrosis factor-α concentration in patients with severe sepsis/septic shock, but this effect did not translate into clinical benefit.
Gordon R. Bernard, Bruno François, Jean-Paul Mira, Jean Louis Vincent, R. Phillip Dellinger, James A. Russell, Steven P. LaRosa, Pierre‐François Laterre, Mitchell M. Levy, Wayne M. Dankner, Nicola Schmitt, Justin P.O. Lindemann, Xavier Wittebole (2013). Evaluating the Efficacy and Safety of Two Doses of the Polyclonal Anti-Tumor Necrosis Factor-α Fragment Antibody AZD9773 in Adult Patients With Severe Sepsis and/or Septic Shock. , 42(3), DOI: https://doi.org/10.1097/ccm.0000000000000043.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2013
Authors
13
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1097/ccm.0000000000000043
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
